A Phase 1 Study of Prophylactic Anakinra To Mitigate ICANS in Patients With Large B-Cell Lymphoma

Authors

Paolo Strati
Andrew Jallouk
Qing Deng
Xubin Li
Lei Feng
Ryan Sun
Sherry Adkins
Swapna Johncy
Taylor Cain
Raphael E Steiner
Sairah Ahmed
Dai Chihara
Luis E Fayad
Swaminathan P Iyer
Sandra Horowitz
Loretta J Nastoupil
Ranjit Nair
Ahmed Hassan
Taher E Daoud
Misha Hawkins
Maria A Rodriguez
Elizabeth J Shpall
Jeremy L Ramdial
Partow Kebriaei
David S Hong
Jason R Westin
Sattva S Neelapu
Michael R Green

Publication Date

11-14-2023

Journal

Blood Advances

DOI

10.1182/bloodadvances.2023010653

PMID

37389847

PMCID

PMC10692290

PubMedCentral® Posted Date

11-14-2023

PubMedCentral® Full Text Version

Post-print

Keywords

Humans, Interleukin 1 Receptor Antagonist Protein, Lymphoma, Large B-Cell, Diffuse, Immunotherapy, Adoptive

Published Open-Access

yes

Recommended Citation

Strati, Paolo; Jallouk, Andrew; Deng, Qing; et al., "A Phase 1 Study of Prophylactic Anakinra To Mitigate ICANS in Patients With Large B-Cell Lymphoma" (2023). Faculty, Staff and Student Publications. 4490.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4490